The effect of different digoxin concentrations on heart tissue and antioxidant status in iron-overloaded rats
Publish place: ARYA Atherosclerosis، Vol: 14، Issue: 2
Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 117
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_RYA-14-2_001
تاریخ نمایه سازی: 2 شهریور 1401
Abstract:
BACKGROUND: Thalassaemia is a hereditary disorder and has an economic burden on patients and the government. The most prevalent complication in these patients is iron overload which is followed by cardiomyopathy. Digoxin is considered as a treatment against heart failure in thalassaemia. The present study evaluated the effect of two digoxin concentrations on iron content and antioxidative defense in cardiac tissue of iron-overloaded rats.METHODS: The study was conducted on ۴۸ rats which were divided into ۶ groups. Group ۱ was the control group and did not receive any treatment and group ۲ was the iron overload group. In addition groups ۳ and ۴ were the digoxin control groups which received ۱ and ۵ mg/kg/day of digoxin, respectively. Groups ۵ and ۶ received ۱ and ۵ mg/kg/day of digoxin plus iron-dextran, respectively. After ۱ month, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPX), and total antioxidant status (TAS) were assessed in cardiac tissues.RESULTS: Co-administration of iron-dextran and digoxin (۱ and ۵ mg/kg/day) significantly increased SOD and TAS levels (P < ۰.۰۰۱۰) and reduced MDA (P < ۰.۰۰۱۰) in heart tissue compared to control and iron overload groups. GPX levels significantly reduced in groups ۵ and ۶ (iron + digoxin ۱ (P < ۰.۰۵۰۰) and iron + digoxin ۵) (P < ۰.۰۰۱۰) compared to the iron control group.CONCLUSION: Digoxin remarkably facilitates iron uptake by cardiomyocytes by affecting other channels such as L-type and T-type Ca۲+ channels (LTCC and TTCC). Digoxin administration in the iron-overloaded rat model deteriorated antioxidative parameters and increased iron entry into heart tissue at higher doses. Therefore, in patients with beta thalassaemia major, digoxin must be administered with great care and serum iron and ferritin must be regularly monitored.
Keywords:
Authors
Beydolah Shahouzehi
Assistant Professor, Student Research Committee AND Physiology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
Hamid Reza Nasri
Associate Professor, Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
Yaser Masoumi-Ardakani
PhD Candidate, Physiology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :